Gilead (NASDAQ: GILD ) reported third quarter EPS of $2.02, $0.51 better than the analyst estimate of $1.51. Revenue for the quarter came in at $7.54B versus the consensus estimate of $7.01B. Guidance
Gilead sees FY 2024 EPS of $4.25-$4.45 versus the analyst consensus of $3.81.
Gilead's stock price closed at $91.69. It is up 24.48% in the last 3 months and up 13.75% in the last 12 months.
Gilead saw 2 positive EPS revisions and 17 negative EPS revisions in the last 90 days. See Gilead's stock price’s past reactions to earnings here.
According to InvestingPro, Gilead's Financial Health score is "good performance".
Check out Gilead's recent earnings performance , and Gilead's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Source: Investing.com